• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION SYNERGY; CORONARY DRUG-ELUTING STENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION SYNERGY; CORONARY DRUG-ELUTING STENT Back to Search Results
Model Number 10617
Device Problem Material Deformation (2976)
Patient Problems No Consequences Or Impact To Patient (2199); No Clinical Signs, Symptoms or Conditions (4582)
Event Date 11/17/2020
Event Type  malfunction  
Event Description
It was reported that stent damage occurred.The 3.0x12mm target lesion was located in the left circumflex (lcx) artery.A 3.00x12mm synergy drug-eluting stent was advanced for treatment.However, it was noted that the distal end of the stent struts were lifted up due to the scratch with the proximal end of the lcx.The procedure was completed with another of the same device.There were no patient complications and the patient was stable.
 
Manufacturer Narrative
Device evaluated by mfr.: synergy ous mr 3.00 x 12 mm stent delivery system was returned for analysis.A visual examination of the stent identified that the crimped stent was flared at the proximal and distal ends of the stent.The undamaged crimped stent was measured and the result was within maximum crimped stent profile measurement.The balloon cones were reviewed, and no issues were noted.The balloon wings were tightly wrapped and evenly folded and were not subjected to positive pressure.A visual and microscopic examination of the tip showed no signs of damage.A visual and tactile examination of the hypotube found no issues with the delivery system.A visual and tactile examination of the outer and mid-shaft section and visual examination of the inner lumen found no issues with the extrusion shaft.No other issues were identified during the product analysis.
 
Event Description
It was reported that stent damage occurred.The 3.0x12mm target lesion was located in the left circumflex (lcx) artery.A 3.00x12mm synergy drug-eluting stent was advanced for treatment.However, it was noted that the distal end of the stent stent struts were lifted up due to the scratch with the proximal end of the lcx.The procedure was completed with another of the same device.There were no patient complications and the patient was stable.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SYNERGY
Type of Device
CORONARY DRUG-ELUTING STENT
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
two scimed place
maple grove MN 55311
MDR Report Key11171804
MDR Text Key226858794
Report Number2134265-2021-00312
Device Sequence Number1
Product Code NIQ
Combination Product (y/n)N
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,distri
Type of Report Initial,Followup
Report Date 02/24/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date01/19/2022
Device Model Number10617
Device Catalogue Number10617
Device Lot Number0025102592
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer01/25/2021
Initial Date Manufacturer Received 01/07/2021
Initial Date FDA Received01/14/2021
Supplement Dates Manufacturer Received02/16/2021
Supplement Dates FDA Received02/24/2021
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Age68 YR
Patient Weight89
-
-